David Azorsa
6Patents
2h-index
6Co-inventors
40Inventor score
Filing activity: Feb 24, 2005 → Mar 17, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7402389B2 | Compositions and methods for prognosis of cancers | Chemistry; Metallurgy | 26 | Expired |
| US9738717B2 | Hybridoma clones, monoclonal antibodies, and methods of use | Physics | 6 | Active |
| US9611319B2 | Hybridoma clones and monoclonal antibodies to fibroblast growth factor 4 | Chemistry; Metallurgy | 0 | Active |
| US9193785B2 | Hybridoma clones and monoclonal antibodies to ING4 | Chemistry; Metallurgy | 0 | Active |
| US9850303B2 | Hybridoma clones and monoclonal antibodies to tetraspanin 8 | Chemistry; Metallurgy | 0 | Active |
| US9862773B2 | Hybridoma clones and monoclonal antibodies to CD9 | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.